Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 29, 2022 at 06:36 am EDT
Guizhou Xinbang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 1,578.35 million compared to CNY 1,460.05 million a year ago. Revenue was CNY 1,578.35 million compared to CNY 1,460.05 million a year ago. Net income was CNY 73.48 million compared to CNY 72.18 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.05 a year ago. Diluted earnings per share from continuing operations was CNY 0.04 compared to CNY 0.05 a year ago.